Intensity Therapeutics Statistics

Total Valuation

INTS has a market cap or net worth of $9.11 million. The enterprise value is $6.66 million.

Market Cap	9.11M
Enterprise Value	6.66M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

INTS has 15.18 million shares outstanding. The number of shares has increased by 61.40% in one year.

Current Share Class	15.18M
Shares Outstanding	15.18M
Shares Change (YoY)	+61.40%
Shares Change (QoQ)	+4.32%
Owned by Insiders (%)	22.83%
Owned by Institutions (%)	10.74%
Float	6.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.11
P/TBV Ratio	3.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.05.

Current Ratio	1.92
Quick Ratio	1.48
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -202.34% and return on invested capital (ROIC) is -126.60%.

Return on Equity (ROE)	-202.34%
Return on Assets (ROA)	-93.90%
Return on Invested Capital (ROIC)	-126.60%
Return on Capital Employed (ROCE)	-547.72%
Revenue Per Employee	n/a
Profits Per Employee	-$2.32M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-84.56%
50-Day Moving Average	1.96
200-Day Moving Average	2.99
Relative Strength Index (RSI)	16.95
Average Volume (20 Days)	298,119

Short Selling Information

The latest short interest is 41,542, so 0.27% of the outstanding shares have been sold short.

Short Interest	41,542
Short Previous Month	57,293
Short % of Shares Out	0.27%
Short % of Float	0.61%
Short Ratio (days to cover)	1.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.59M
Pretax Income	-15.07M
Net Income	-16.27M
EBITDA	n/a
EBIT	-16.59M
Earnings Per Share (EPS)	-$1.17

Full Income Statement

Balance Sheet

The company has $2.59 million in cash and $138,000 in debt, giving a net cash position of $2.45 million or $0.16 per share.

Cash & Cash Equivalents	2.59M
Total Debt	138,000
Net Cash	2.45M
Net Cash Per Share	$0.16
Equity (Book Value)	2.92M
Book Value Per Share	0.19
Working Capital	1.61M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-15.22M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INTS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.40%
Shareholder Yield	-61.40%
Earnings Yield	-178.48%
FCF Yield	n/a

Analyst Forecast

The average price target for INTS is $8.50, which is 1,302.64% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	1,302.64%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1